Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 8
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Experimental blood glucose interval identification of patients with type 1 diabetes

  • Laguna Sanz, Alejandro José
  • Rossetti, Paolo
  • Ampudia Blasco, F. Javier
  • Vehí, Josep
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Many problems are confronted when characterizing a type 1 diabetic patient such as model mismatches, noisy inputs, measurement errors and huge variability in the glucose profiles. In this work we introduce a new identification method based on interval analysis where variability and model imprecisions are represented by an interval model as parametric uncertainty. The minimization of a composite cost index comprising: (1) the glucose envelope width predicted by the interval model, and (2) a Hausdorff-distance-based prediction error with respect to the envelope, is proposed. The method is evaluated with clinical data consisting in insulin and blood glucose reference measurements from 12 patients for four different lunchtime postprandial periods each. Following a “leave-one-day-out” cross-validation study, model prediction capabilities for validation days were encouraging (medians of: relative error = 5.45%, samples predicted = 57%, prediction width = 79.1 mg/dL). The consideration of the days with maximum patient variability represented as identification days, resulted in improved prediction capabilities for the identified model (medians of: relative error = 0.03%, samples predicted = 96.8%, prediction width = 101.3 mg/dL). Feasibility of interval models identification in the context of type 1 diabetes was demonstrated., The research leading to these results has received funding from the Spanish Ministry of Science and Innovation under grant DPI2010-20764-C02-01, the European Union Seventh Framework Programme (FP7/2007–2013) under grant agreement FP7-PEOPLE-2009-IEF, Ref 252085 and the GeneralitatValenciana through Grant GV/2012/085. The authors acknowledge the collaboration of Sara Correa, Geles Viguer and Pepa Gabaldón from the Diabetes Reference Unit in the Clinic University Hospital of Valencia, and the selfless participation of all the patients involved in the experiments from which data were obtained.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Adaptive calibration algorithm for plasma glucose estimation in continuous glucose monitoring

  • Barceló-Rico, Fátima
  • Rossetti, Paolo
  • Vehi, Josep
  • Diez, José-Luís|||0000-0002-5659-1212
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Minimally or noninvasive continuous glucose monitors estimate plasma glucose from compartments alternative to blood, and may revolutionize the management of diabetes. However, the accuracy of current devices is still poor and it may partly depend on low performance of the implemented calibration algorithm. Here, a new adaptive calibration algorithm based on a population local-model-based intercompartmental glucose dynamic model is proposed. The novelty consists in the adaptation of data normalization parameters in real time to estimate and compensate patient's sensitivity variations. Adaptation is performed to minimize mean absolute relative deviation at the calibration points with a time window forgetting strategy. Four calibrations are used: preprandial and 1.5 h postprandial at two different meals. Two databases are used for validation: 1) a 9-hCGMSGold (Medtronic, Northridge, USA) time series with paired reference glucose values from a clinical study in 17 subjects with type 1 diabetes; 2) data from 30 virtual patients (UVa simulator, Virginia, USA), where inter-and intrasubject variability of sensor's sensitivity were simulated. Results show how the adaptation of the normalization parameters improves the performance of the calibration algorithm since it counteracts sensor sensitivity variations. This improvement is more evident in one-week simulations., Manuscript received April 17, 2012; revised September 10, 2012 and January 21, 2013; accepted March 11, 2013. Date of publication March 19, 2013; date of current version May 1, 2013. This work was supported in part by the Spanish Ministry of Science and Innovation under Project DPI2010-20764-C02 and in part by the European Union under Grant FP7-PEOPLE-2009-IEF, Ref 252085. The work of F. Barcelo-Rico was supported by the Spanish Ministry of Education (FPU AP2008-02967).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Safety Auxiliary Feedback Element for the Artificial Pancreas in Type 1 Diabetes

  • Revert Tomás, Ana
  • Garelli, Fabricio
  • De Battista, Hernan
  • Rossetti, Paolo
  • Picó, Jesús|||0000-0003-4144-3521
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] The artificial pancreas aims at the automatic deliv-ery of insulin for glycemic control in patients with type 1 diabetes, i.e., closed-loop glucose control. One of the challenges of the arti-ficial pancreas is to avoid controller overreaction leading to hypo-glycemia, especially in the late postprandial period. In this study, an original proposal based on sliding mode reference conditioning ideas is presented as a way to reduce hypoglycemia events induced by a closed-loop glucose controller. The method is inspired in the intuitive advantages of two-step constrained control algorithms. It acts on the glucose reference sent to the main controller shaping it so as to avoid violating given constraints on the insulin-on-board. Some distinctive features of the proposed strategy are that 1) it provides a safety layer which can be adjusted according to medical criteria; 2) it can be added to closed-loop controllers of any nature; 3) it is robust against sensor failures and overestimated prandial insulin doses; and 4) it can handle nonlinear models. The method is evaluated in silico with the ten adult patients available in the FDA-accepted UVA simulator., This work was supported in part by the FEDER-CICYT under Grant DPI2008-06880-C03-01, Grant DPI2011-28112-C04-01, and Grant DPI2010-20764-C02, in part by the European Union Seventh Framework Programme (FP7/2007-2013) under Grant FP7-PEOPLE-2009-IEF Ref 252085, and in part by the Argentinian Government under Grant ANPCyT PICT-2011-0888, Grant CONICET PIP112-2011-00361, and Grant UNLP I164. The work of A. Revert was supported by the Spanish Ministry of Science and Innovation fellowship under Grant FPI BES-2009-020327.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

A multiple local models approach to accuracy improvement in continuous glucose monitoring

  • Barceló Rico, Fátima
  • Rossetti ., Paolo
  • Bondía Company, Jorge|||0000-0001-7286-3719
  • Diez, José-Luís|||0000-0002-5659-1212
[EN] Background: Continuous glucose monitoring (CGM) devices estimate plasma glucose (PG) from measurements in compartments alternative to blood. The accuracy of currently available CGM is yet unsatisfactory and may depend on the implemented calibration algorithms, which do not compensate adequately for the differences of glucose dynamics between the compartments. Here we propose and validate an innovative calibration algorithm for the improvement of CGM performance. Methods: CGM data from GlucoDay (R) (A. Menarini, Florence, Italy) and paired reference PG have been obtained from eight subjects without diabetes during eu-, hypo-, and hyperglycemic hyperinsulinemic clamps. A calibration algorithm based on a dynamic global model (GM) of the relationship between PG and CGM in the interstitial space has been obtained. The GM is composed by independent local models (LMs) weighted and added. LMs are defined by a combination of inputs from the CGM and by a validity function, so that each LM represents to a variable extent a different metabolic condition and/or sensor-subject interaction. The inputs best suited for glucose estimation were the sensor current I and glucose estimations (G) over cap, at different time instants [I-k, Ik-1, (G) over cap (k-1)] (IIG). In addition to IIG, other inputs have been used to obtain the GM, achieving different configurations of the calibration algorithm. Results: Even in its simplest configuration considering only IIG, the new calibration algorithm improved the accuracy of the estimations compared with the manufacturer's estimate: mean absolute relative difference (MARD) = 10.8 +/- 1.5% versus 14.7 +/- 5.4%, respectively (P = 0.012, by analysis of variance). When additional exogenous signals were considered, the MARD improved further (7.8 +/- 2.6%, P<0.05). Conclusions: The LM technique allows for the identification of intercompartmental glucose dynamics. Inclusion of these dynamics into the calibration algorithm improves the accuracy of PG estimations., The authors acknowledge the partial funding of this work by the Spanish Ministry of Science and Innovation projects DPI2007-66728-C02-01 and DPI2010-20764-C02-01 and by the European Union through FEDER funds and grant FP7-PEOPLE-2009-IEF, Reference 252085. F.B.R. is the recipient of a fellowship (FPU AP2008-02967) from the Spanish Ministry of Education.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Evaluation of a novel continuous glucose monitoring-based method for mealtime insulin dosing - the iBolus - in subjects with type 1 diabetes using continuous subcutaneous insulin infusion therapy: a randomized controlled trial

  • Rossetti, Paolo
  • Ampudia Blasco, F. Javier
  • Laguna Sanz, Alejandro José
  • Revert Tomás, Ana
  • Vehí Casellas, Josep
  • Ascaso, Juan F.
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Objective: Prandial insulin dosing is an empirical practice associated frequently with poor reproducibility in postprandial glucose response. Based on continuous glucose monitoring (CGM), a method for prandial insulin administration (iBolus) is presented and evaluated for people with type 1 diabetes using CSII therapy. Subjects and Methods: An individual patient¿s model for a 5-h postprandial period was obtained from 6-day ambulatory CGM and used for iBolus calculation in 12 patients with type 1 diabetes. In a double-blind, crossover study each patient underwent four meal tests with 40 g or 100 g of carbohydrates (CHOs), both on two occasions. For each meal, the iBolus or the traditional bolus (tBolus) was given before mealtime (t 0) in a randomized order. We measured the postprandial glycemic response as the area under the curve of plasma glucose (AUC-PG0¿5h) and variability as the individual coef¿cient of variation (CV) of AUC-PG0¿5h. The contribution of the insulin-to-CHO ratio, CHO, plasma glucose at t 0 (PGt0), and insulin dose to AUC-PG0¿5h and its CV was also investigated. Results: AUC-PG0¿5h was similar with either bolus for 40-g (iBolus vs. tBolus, 585.5¿127.5 vs. 689.2¿180.7 mg/dL$h) or 100-g (752.1¿237.7 vs. 760.0¿263.2 mg/dL$h) CHO meals. A multiple regression analysis revealed a signi¿cant model only for the tBolus, with PGt0 being the best predictor of AUC-PG0¿5h explaining approximately 50% of the glycemic response. Observed variability was greater with the iBolus (CV, 16.7¿15.3% vs. 10.1¿12.5%) but independent of the factors studied. Conclusions: A CGM-based algorithm for calculation of prandial insulin is feasible, although it does not reduce unpredictability of individual glycemic responses. Causes of variability need to be identi¿ed and analyzed for further optimization of postprandial glycemic control., We are grateful to Mrs. Sara Correa, Fundacion INCLIVA-Hospital Clinico Universitario de Valencia, and Mrs. Geles Viguer, Hospital Clinico Universitario de Valencia, for their invaluable help in conducting the study. We also thanks Dr. Carmine Fanelli, University of Perugia, Dr. Howard Zisser, Sansum Diabetes Research Institute, and Prof. Alberto Ferrer, Universitat Politecnica de Valencia, for their suggestions on study design and data analysis. The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007/2013) under grant agreement 252085 and from the Spanish Ministry of Science under grants DPI2010-20764-C02-01 and DPI2011-28112-C04-01.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Identification of intra-patient variability in the postprandial response of patients with type 1 diabetes

  • Laguna Sanz, Alejandro José
  • Rossetti, Paolo
  • Ampudia Blasco, F. Javier
  • Vehí, Josep
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Background Identification of individualized models for patients with type 1 diabetes is of vital importance for the development of a successful artificial pancreas and other model-based strategies of insulin treatment. However, the huge intra-patient glycemic variability frequently prevents the identification of reliable models, especially in the postprandial period. In this work, the identification of postprandial models characterizing intra-patient variability is addressed. Methods Regarding the postprandial response, uncertainties due to physiological variability, input errors in insulin infusion rate and in meal content estimation are characterized by means of interval models, which predict a glucose envelope containing all possible patient responses according to the model. Multi-objective optimization is performed over a cohort of virtual patients, minimizing both the fitting error and the output glucose envelope width. A Pareto Front is then built ranging from classic identification representing average behaviors to interval identification guaranteeing full enclosure of the measurements. A method for the selection of the best individual in the Pareto Front for identification from home monitoring data with a continuous glucose monitor is presented, reducing the overestimation of patient's variability due to monitor inaccuracies and noise. Results Identification using glucose reference data provide model bands that accurately fit all data points in the used virtual data set. Identification from continuous glucose monitor data, using two different width estimation procedures yield very similar prediction capabilities of around 60% of the data points predicted, and less than a 5% average error. Conclusions In this work, a new approach to evaluate intra-patient variability in the identification of postprandial models is presented. The proposed method is feasible and shows good prediction capabilities in a 5-h time horizon as compared to reference measurements., This work received funding from the Spanish Ministry of Science and Innovation under grant DPI2010-20764-C02, from the Generalitat Valenciana under project GV/2012/085, andfromthe European UnionSeventhFramework Programme (FP7/2007-2013) under grant agreement FP7-PEOPLE-2009-IEF, Ref 252085. The authors would like to acknowledge the collaboration of Sara Correa, Geles Viguer and Pepa Gabaldón of the Diabetes Reference Unit from the Clinic University Hospital of Valencia and, in particular, all the patients for participating in the study used in this work.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Plasma Insulin Levels and Hypoglycemia Affect Subcutaneous Interstitial Glucose Concentration

  • Moscardo-Garcia, Vanessa
  • Ampudia-Blasco, Francisco Javier
  • Fanelli, Carmine G
  • Lucidi, Paola
  • Rossetti, Paolo
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Background: Continuous glucose monitoring (CGM) accuracy during hypoglycemia is suboptimal. This might be partly explained by insulin or hypoglycemia-induced changes in the plasma interstitial subcutaneous (SC) fluid glucose gradient. The aim of the present study was to assess the role of plasma insulin (PI) and hypoglycemia itself in the plasma and interstitial SC fluid glucose concentration in patients with type 1 diabetes mellitus. Methods: Eleven subjects with type 1 diabetes (age 36.59.1 years, HbA(1c) 7.90.4% [62.8 +/- 2.02mmol/mol]; mean +/- standard deviation) were evaluated under hyperinsulinemic euglycemia and hypoglycemia. Each subject underwent two randomized crossover clamps with either a primed 0.3 (low insulin) or 1mU/(kgmin) (high insulin) insulin infusion. The raw CGM signal was normalized with median preclamp values to obtain a standardized measure of the interstitial glucose (IG) concentration before statistical analysis. Results: The mean PI concentration was greater in high insulin studies (HISs) versus low insulin studies (LISs) (412.89 +/- 13.63 vs. 177.22 +/- 10.05pmol/L). During hypoglycemia, glucagon, adrenaline, free fatty acids, glycerol, and beta-OH-butyrate were higher in the LIS (P<0.0001). Likewise, the IG concentration was significantly different (P<0.0001). This was due to lower IG concentration than plasma glucose (PG) concentration during the euglycemic hyperinsulinemic phases in the HIS. In contrast, no difference was observed during hypoglycemia. This was the result of an unchanged PG/IG gradient during the entire LIS, while in the HIS, this gradient increased during the hyperinsulinemic euglycemia phase. Conclusion: Both PI levels and hypoglycemia affect the relationship between IG and PG concentration. ClinicalTrials.gov Identifier: NCT01714895., The research leading to these results received funding from the European Union Seventh Framework Programme (FP7/2007/2013) under the grant agreement 252085 and FEDER funds, as well as the Spanish Ministry of Economy and Competitiveness (MINECO) under the grants DPI2013-46982-C2-1-R and DPI2016-78831-C2-1-R.V.M. is recipient of an FPU grant ref FPU13/04253. We are grateful to Mrs. Sara Correa, Fundacion INCLIVA-Hospital Clinico Universitario de Valencia, and Mrs. Geles Viguer, Hospital Clinico Universitario de Valencia, for their invaluable help in conducting the study.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Postprandial performance of Dexcom® SEVEN® PLUS and Medtronic® Paradigm® Veo : Modeling and statistical analysis

  • Laguna Sanz, Alejandro José
  • Rossetti, Paolo
  • Ampudia Blasco, F. Javier
  • Vehí, Josep
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Background Minimizing excessive postprandial glucose excursion is still an unmet need in treating diabetes. This work addresses the analysis and modeling in the postprandial state of two commercial CGM devices. Methods Twelve patients with type 1 diabetes were studied in the postprandial state on four different occasions under controlled conditions. Each time, we performed simultaneous glucose monitoring using the Dexcom SEVEN® PLUS (47 datasets) and the Medtronic Paradigm® Veo™ (42 datasets). The following statistical properties of the error signal were analyzed and modeled sequentially for the two devices: the lag time, the error stationarity, the error probability distribution and the time correlation. Finally, models were built for sensor simulation in silico studies. Results Lag time followed an exponential probability distribution for both monitors (μsevenplus = 108, μveo = 1.69). Standard deviation and mean of the error signal, calculated as time-dependent signals across the population of sensors, were time-varying and correlated with the reference value and its rate of change, respectively. In both cases, a high variability of postprandial behaviors was observed. After non-stationarity compensation, a logistic distribution was obtained for the SEVEN® PLUS error (close to normal distribution). Regarding the Paradigm® Veo™, a multimodal distribution was obtained, which turned into normal after elimination of five “unstable” sensors. Finally, a first order autoregressive model fitted the SEVEN® PLUS error time-series while a third-order filter was necessary for the Paradigm® Veo™. Conclusions The Paradigm® Veo™ device exhibited greater delay variability with higher delay time and higher probability of abnormal sensor behaviors as compared to the SEVEN® PLUS device. In both cases, the observed variability may have important clinical implications in postprandial performance. Therefore, further improvements are needed in calibration algorithms to reduce this variability., The research leading to these results has received funding from the Spanish Ministry of Science and Innovation under grant DPI2010-20764-C02-01, the European Union Seventh Framework Programme (FP7/2007–2013) under grant agreement FP7-PEOPLE-2009-IEF, Ref 252085 and the Generalitat Valenciana through Grant GV/2012/085. The authors acknowledge the collaboration of Sara Correa, Geles Viguer and Pepa Gabaldón from the Diabetes Reference Unit in the Clinic University Hospital of Valencia, and the selfless participation of all the patients involved in the experiments from which data were obtained.